Albany Molecular Lands NIH Contract | Chemical & Engineering News
Volume 89 Issue 35 | p. 17 | Concentrates
Issue Date: August 29, 2011

Albany Molecular Lands NIH Contract

Department: Business
News Channels: Biological SCENE
Keywords: contract research, medicinal chemistry

Albany Molecular Research Inc. has won a five-year contract from NIH and the National Institute of Neurological Disorders & Stroke to provide chemistry and other drug discovery technology in support of NINDS’s Medicinal Chemistry for Neurotherapeutics Program. AMRI will receive $10 million in funding for the first phase of the project, with the objective of delivering at least one Phase I clinical-trial candidate. The firm stands to receive as much as $43 million for the full contract. AMRI has collaborated with NINDS since 2005 on treating spinal muscular atrophy.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment